Live Breaking News & Updates on Valiant Evo Global Clinical Trial|Page 1

Stay updated with breaking news from Valiant evo global clinical trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Medtronic Recalls Unused Valiant Navion Thoracic Stent Graft System


Medtronic Recalls Unused Valiant Navion Thoracic Stent Graft System
FRIDLEY (dpa-AFX) - Medtronic plc has recalled unused Medtronic Valiant Navion thoracic stent graft system globally, according to the U.S. Food and Drug Administration. The Irish medical technology company also informed physicians to immediately cease use of the device until further notice.
The company initiated the recall following information obtained from the Valiant Evo Global Clinical Trial indicating that three patients in the trial were observed to have stent fractures, two of which have confirmed type IIIb endoleaks. One patient death was reported.
Following these observations, an independent imaging laboratory reviewed all available images from patients enrolled in the Valiant Evo Global Clinical Trial. It was found that seven out of 87 patients were observed to have stent ring enlargement beyond the design specification. Those observations require further assessment to determine potential cli ....

Drug Administration , Medtronic Valiant Navion , Valiant Evo Global Clinical Trial , Valiant Evo Global Clinical , Valiant Navion , வீரம் எவோ உலகளாவிய மருத்துவ சோதனை , வீரம் எவோ உலகளாவிய மருத்துவ ,

Medtronic Recalls Unused Valiant Navion Thoracic Stent Grafts


Medtronic Recalls Unused Valiant Navion Thoracic Stent Grafts
Physicians directed to immediately cease use of the Medtronic Valiant Navion thoracic stent graft system
February 23, 2021 Medtronic has voluntarily issued a global recall of unused Medtronic Valiant Navion thoracic stent graft system and informed physicians to immediately cease use of the device until further notice.
Medtronic initiated this action in response to information recently obtained from the Valiant Evo Global Clinical Trial indicating that three patients in the Valiant Evo Global Clinical Trial were observed to have stent fractures. Two of these stent fractures resulted in confirmed type IIIb endoleaks. One patient death was reported, the company said. ....

Nina Goodheart , Drug Administration , Vascular Group At Medtronic , Medtronic Valiant Navion , Valiant Evo Global Clinical Trial , Valiant Evo Global Clinical , Cardiac Vascular Group , Management Recommendations , Those Implanted With , Valiant Navion , Watch Adverse Event Reporting , வாஸ்குலர் குழு இல் மெதிடிறோனிக் , வீரம் எவோ உலகளாவிய மருத்துவ சோதனை , வீரம் எவோ உலகளாவிய மருத்துவ , இதய வாஸ்குலர் குழு ,

Medtronic, Inc. (NYSE:MDT) - Medtronic Recalls Thoracic Stent Graft After Reported Patient Death In Trial

Medtronic, Inc. (NYSE:MDT) - Medtronic Recalls Thoracic Stent Graft After Reported Patient Death In Trial
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Medtronic Plc , Valiant Navion , Valiant Evo Global Clinical Trial , Valiant Evo , மெதிடிறோனிக் ப்ல் , வீரம் எவோ உலகளாவிய மருத்துவ சோதனை , வீரம் எவோ ,